Press releases
- A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
- Soligenix Announces Reverse Stock Split
- Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
- Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
- Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
- SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
- Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
- Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
- Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
- Soligenix to Present at Upcoming Conferences
More ▼
Key statistics
On Friday, Soligenix Inc (0A6I:LSE) closed at 4.53, 27.42% above the 52 week low of 3.56 set on Jun 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 4.53 |
Average volume | 498.10 |
---|---|
Shares outstanding | 987.49k |
Free float | 986.83k |
P/E (TTM) | -- |
Market cap | 4.01m USD |
EPS (TTM) | -11.83 USD |
Data delayed at least 20 minutes, as of Jun 14 2024 17:07 BST.
More ▼